Nivatrotamab (Anti-CD3 & GD2)

製品コード：A4062 Batch: A406201

Nivatrotamab is a humanized bispecific antibody targeting GD2 on tumor cells and CD3 on T cells to enhance immune activation. It is being developed for the treatment of metastatic small cell lung cancer (SCLC) by recruiting T cells to attack tumors. M. W 200.96 kDa

製品説明

CAS No.	N/A
Source	CHO
Storage (From the date of receipt)	-80℃(avoid freeze-thaw cycles)
Shipping	Shipped under low temperature conditions
Purity	99%
Protein concentration	5.248mg/ml
Endotoxin Level	＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。